Metformin Hydrochloride Tablets IP 1000 mg
Formulation Overview: High-strength 1000 mg biguanide antihyperglycemic tablet reducing hepatic gluconeogenesis and improving peripheral insulin sensitivity without hypoglycemia or weight gain. Formulated with Metformin Hydrochloride IP 1000 mg (1000 mg) in High-Strength Film-Coated Tablets dosage form under Anti-Diabetic Medication, manufactured to IP / BP / USP Compendial standards and supplied in 10 x 10 Alu-Alu / Blister Pack with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-223 |
| Catalog Reference | AKP-223 · SN 223 |
| Therapeutic Sector | Anti-Diabetic Medication |
| Dosage Form | High-Strength Film-Coated Tablets |
| Active Ingredient | Metformin Hydrochloride IP 1000 mg |
| Strength / Purity | 1000 mg |
| Clinical Indication | First-line Type 2 diabetes mellitus management, prediabetes, and polycystic ovary syndrome (PCOS) insulin resistance |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 10 x 10 Alu-Alu / Blister Pack |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C in a dry place, protect from light and moisture |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |